Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Nature medicine·2026
Same author

Pulmonary and cerebral damage in COVID-19 survivors: is there any association?

Annals of medicine·2026
Same author

Distinct Resting-State Functional Connectivity Profiles in ADHD with and without Prenatal Alcohol Exposure.

medRxiv : the preprint server for health sciences·2026
Same author

Anterior middle cingulate cortex gamma-aminobutyric acid level is elevated in children with both familial and prenatal alcohol exposure-associated attention deficit hyperactivity disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Imaging diagnosis of cystic intraparenchymal brain neoplasms.

Japanese journal of radiology·2026
Same author

Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801).

AJNR. American journal of neuroradiology·2026

Related Experiment Video

Updated: Jul 5, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K

Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction.

Nicholas S Cho1,2,3,4, Francesco Sanvito1,2, Viên Lam Le1,2,3

  • 1From the UCLA Brain Tumor Imaging Laboratory (N.S.C., F.S., V.L.L., S.O., A.T., J.Y., C.R., B.M.E.), Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, Los Angeles, California.

AJNR. American Journal of Neuroradiology
|January 18, 2024
PubMed
Summary
This summary is machine-generated.

Quantifying the T2-FLAIR mismatch sign using digital subtraction maps provides objective measurements for classifying isocitrate dehydrogenase (IDH)-mutant astrocytomas. This automated tool achieves 100% specificity but does not improve radiologist assessment.

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K
Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

9.4K

Related Experiment Videos

Last Updated: Jul 5, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K
Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

9.4K

Area of Science:

  • Neuro-oncology
  • Radiology
  • Medical Imaging

Background:

  • The T2-FLAIR mismatch sign is a specific biomarker for IDH-mutant astrocytomas.
  • Current visual assessment of the T2-FLAIR mismatch sign has limitations.

Purpose of the Study:

  • To quantify the T2-FLAIR mismatch sign using digital subtraction in nonenhancing diffuse gliomas.
  • To assess the diagnostic performance and subregion characteristics of quantitative T2-FLAIR mismatch.

Main Methods:

  • Two cohorts of treatment-naïve gliomas were analyzed (n=71 TCIA, n=34 institutional).
  • Digital subtraction maps (T2-weighted minus FLAIR) were used to segment T2-FLAIR mismatched and nonmismatched subregions.
  • Radiologists assessed the T2-FLAIR mismatch sign with and without subtraction maps.

Main Results:

  • Quantitative thresholds for T2-FLAIR mismatch volume showed high specificity (up to 100%) for classifying IDH-mutant astrocytomas.
  • T2-FLAIR mismatch volume percentage correlated with tumor grade and size.
  • Digital subtraction maps did not significantly improve radiologist interreader agreement, sensitivity, or specificity.

Conclusions:

  • T2-FLAIR digital subtraction maps offer an automated, objective method for classifying IDH-mutant astrocytomas based on quantitative T2-FLAIR mismatch volume.
  • This quantitative approach allows for detailed subregion analysis but does not enhance visual assessment by radiologists.